Strategies for eliminating death from gastric cancer in Japan

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 90, Issue 7, 2014, Pages 251-258

  Asaka, Masahiro ^a   Mabe, Katsuhiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Elimination of gastric cancer; Gastric cancer prevention; H. Pylori associated gastritis; Helicobacter pylori (H. Pylori)

Indexed keywords

HELICOBACTER PYLORI;

CHRONIC DISEASE; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; JAPAN; MALE; MICROBIOLOGY; MORTALITY; PREVALENCE; STOMACH NEOPLASMS;

CHRONIC DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; PREVALENCE; STOMACH NEOPLASMS;

EID: 84923914880     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.90.251     Document Type: Review

References (37)

1. Asaka, M., Sugiyama, T., Nobuta, A., Kato, M., Takeda, H. and Graham, D.Y. (2001) Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6, 294-299.
2. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. and Schlemper, R.J. (2001) Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789.
3. Asaka, M. (2002) Helicobacter pylori infection and gastric cancer. Intern. Med. 41, 1-6.
4. Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., Uemura, N., Murakami, K., Satoh, K. and Sugano, K. (2009) Guidelines for the management of Helicobacter pylori infection in Japan. revised edition. Helicobacter 15, 1-20.
5. Asaka, M., Kato, M. and Sakamoto, N. (2014) Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J. Gastroenterol. 49, 1-8.
6. "Cancer Statistics in Japan" Editorial Board (2012) Survival rate in the member hospitals of the association of clinical cancer centers (Diagnosed in 2000-2004). In Cancer Statistics in Japan- 2012, Foundation for Promotion of Cancer Research, Tokyo, pp. 76-77.
7. Fukao, A., Tsubono, Y., Tsuji, I., Hisamichi, S., Sugahara, N. and Takano, A. (1995) The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study. Int. J. Cancer 60 (1), 45-48.
8. Hisamichi, S. and Sugawara, N. (1984) Mass screening for gastric cancer by X-ray examination. Jpn. J. Clin. Oncol. 11, 211-233.
9. Japanese Ministry of Health, Labour and Welfare (2010) Health Promotion and Community Health Report in 2010. Japanese Ministry of Health, Labour and Welfare, Tokyo.
10. Choi, K.S., Jun, J.K., Park, E.C., Park, S., Jung, K.W., Han, M.A., Choi, I.J. and Lee, H.Y. (2012) Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS ONE 7 (11), e50041.
11. Matsumoto, S., Ishikawa, S. and Yoshida, Y. (2013) Reduction of gastric cancer mortality by endoscopic and radiographic screening in an isolated island: A retrospective cohort study. Aust. J. Rural Health 21 (6), 319-324.
12. International Agency for Research on Cancer, World Health Organization (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 1-241.
13. Matsuo, T., Ito, M., Takata, S., Tanaka, S., Yoshihara, M. and Chayama, K. (2011) Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 16, 415-419.
14. Yoon, H., Kim, N., Lee, H.S., Shin, C.M., Park, Y.S., Lee, D.H., Jung, H.C. and Song, I.S. (2011) Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter 16, 382-388.
15. Nagayo, T., Ito, M., Yokoyama, H. and Komagoe, T. (1965) Early phases of human gastric cancer: Morphological study. Gann 56, 101-120.
16. Nakamura, K., Sugano, H. and Takagi, K. (1968) Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 59, 251-258.
17. Kaneko, E., Nakamura, T., Umeda, N., Fujino, M. and Niwa, H. (1977) Outcome of gastric carcinoma detected by gastric mass survey in Japan. Gut 18, 626-630.
18. Noguchi, Y., Yoshikawa, T., Tsuburaya, A., Motohashi, H., Karpeh, M.S. and Brennan, M.F. (2000) Is gastric carcinoma different between Japan and the United States? Cancer 89, 2237-2246.
19. Hundahl, S.A., Phillips, J.L. and Menck, H.R. (2000) The National Cancer data base report on poor survival of U.S. gastric carcinoma patients with gastrectomy. Cancer 88, 921-932.
20. Dinis-Ribeiro, M., Areia, M., De Vries, A.C., Marcos-Pinto, R., Monteiro-Soares, M., O'Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., Dumonceau, J.M., Machado, J.C., Macedo, G., Malfertheiner, P., Matysiak-Budnik, T., Megraud, F., Miki, K., O'Morain, C., Peek, R.M., Ponchon, T., Ristimaki, A., Rembacken, B., Carneiro, F. and Kuipers, E.J. (2012) Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 44, 74-94.
21. Miehlke, S., Kirsch, C., Dragosics, B., Gschwantler, M., Oberhuber, G., Antos, D., Dite, P., Läuter, J., Labenz, J., Leodolter, A., Malfertheiner, P., Neubauer, A., Ehninger, G., Stolte, M. and Bayerdörffer, E. (2001) Helicobacter pylori and gastric cancer: current status of the Austrian Czech German gastric cancer prevention trial (PRISMA Study). World J. Gastroenterol. 7, 243-247.
22. You, W.C., Brown, L.M., Zhang, L., Li, J.Y., Jin, M.L., Chang, Y.S., Ma, J.L., Pan, K.F., Liu, W.D., Hu, Y., Crystal-Mansour, S., Pee, D., Blot, W.J., Fraumeni, J.F. Jr., Xu, G.W. and Gail, M.H. (2006) Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl. Cancer Inst. 98, 974-983.
23. Ma, J.L., Zhang, L., Brown, L.M., Li, J.Y., Shen, L., Pan, K.F., Liu, W.D., Hu, Y., Han, Z.X., Crystal-Mansour, S., Pee, D., Blot, W.J., Fraumeni, J.F. Jr., You, W.C. and Gail, M.H. (2012) Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J. Natl. Cancer Inst. 104, 488-492.
24. Arima, N., Adachi, K., Katsube, T., Amano, K., Ishihara, S., Watanabe, M. and Kinoshita, Y. (1999) Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment. J. Clin. Gastroenterol. 29, 44-47.
25. Nasu, J., Doi, T., Endo, H., Nishina, T., Hirasaki, S. and Hyodo, I. (2005) Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy 37, 990-993.
26. Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S. and Asaka, M. (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372, 392-397.
27. Kato, M., Asaka, M. and Kikuchi, S. (2012) Longterm follow-up study about preventive effect of H. pylori eradication for the Incidence of metachronous gastric cancer after endoscopic resection of primary early gastric cancer. Gastroenterology 142 (Supple 1), S3.
28. Wu, C.Y., Kuo, K.N., Wu, M.S., Chen, Y.J., Wang, C.B. and Lin, J.T. (2009) Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 137, 1641-1648.
29. National Cancer Control Institute (2013) Cancer Facts and Figures 2013 in the Republic of Korea. 1st edition. Ministry of Health & Welfare and National Cancer Center, Republic of Korea.
30. Inoue, M., Sawada, N., Matsuda, T., Iwasaki, M., Sasazuki, S., Shimazu, T., Shibuya, K. and Tsugane, S. (2012) Attributable causes of cancer in Japan in 2005-systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann. Oncol. 23, 1362-1369.
31. Tsukuma, H., Tanaka, H., Ajiki, W. and Oshima, A. (2005) Liver cancer and its prevention. Asian Pac. J. Cancer Prev. 6, 244-250.
32. Makuuchi, M., Kokudo, N., Arii, S., Futagawa, S., Kaneko, S., Kawasaki, S., Matsuyama, Y., Okazaki, M., Okita, K., Omata, M., Saida, Y., Takayama, T. and Yamaoka, Y. (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol. Res. 38, 37-51.
33. Fujimori, K. (2014) Medical procedures for eradication of H. pylori by E-claim data. GI Forefront 9, 96-98.
34. Asaka, M., Kato, M. and Graham, D. (2010) Strategy for eliminating gastric cancer in Japan. Helicobacter 15, 486-490.
35. Asaka, M. (2013) A new approach for elimination of gastric cancer in Japan. Int. J. Cancer 132, 1272-1276.
36. Akamatsu, T., Ichikawa, S., Okudaira, S., Yokosawa, S., Iwaya, Y., Suga, T., Ota, H. and Tanaka, E. (2011) Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J. Gastroenterol. 46, 1353-1360.
37. Asaka, M. (2009) Cost performance for eradication of H. pylori in prevention of gastric cancer. GI Res. 5, 34-36 (in Japanese).